▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

Pepsico Q1 22 Earnings Conference Call At 8:15 AM ET

By RTTNews Staff Writer ✉ | Published: 4/26/2022 7:15 AM ET

Pepsico Inc. (PEP) will host a conference call at 8:15 AM ET on April 26, 2022, to discuss Q1 22 earnings results.

To access the webcast, log on to https://www.pepsico.com/investors/financial-information/events-and-presentations

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In March 2022

Biotech Stocks Facing FDA Decision In March 2022

Biotech Stocks Facing FDA Decision In February 2022 non small cell lung cancer chemotherapy

Biotech Stocks Facing FDA Decision In February 2022

Latest Updates on COVID-19

193K New Covid Cases, 710 Deaths In U.S.

18K New Covid Cases, 144 Deaths In US

184K New Covid Cases, 860 Deaths In U.S.

Pfizer Signs $3.2 Bln COVID Vaccine Deal With US Government

125K New Covid Cases, 549 Deaths In U.S.

Read More

COVID-19: Drugs in Development

RELATED NEWS

Pepsico Q1 22 Earnings Conference Call At 8:15 AM ET

PepsiCo Q1 Results Climb, Top Estimates; Backs FY22 Core EPS Growth View, Lifts Revenue Growth View

Pepsico Inc Q1 Profit Increases, beats estimates

Follow RTT

Editor's Pick
Most Read
Most Emailed

FCC Authorizes SpaceX To Use Starlink Internet Service On Vehicles In Motion

Loud Muscle Science Recalls Launch Sequence Products

US To Import 17 Mln Bottles Of Infant Formula From New Zealand, Ireland

Children's Sleepwear Sold At Amazon Recalled

Pfizer Signs $3.2 Bln COVID Vaccine Deal With US Government

Samsung Starts Mass Production Of Most Advanced 3-nm Chips

Morphine Sulfate Extended-Release Tablets Recalled Due To Label-Mix Up

FTC Sues Walmart For Facilitating Money Transfer Fraud

Bed Bath & Beyond Q1 Results Miss Estimates

Tesla Cuts 200 Autopilot Jobs, Closes San Mateo Office

FDA Experts Recommend Updated Booster Shots To Fight Contagious Omicron Variant In Fall

Creminelli Recalls Mini Parmesan Salami Stick Products

TD SYNNEX Q2 Results Top Estimates; Reaffirms FY22 Adj. EPS Outlook

General Mills Gains On Upbeat Q4 Results, Increased Dividend

Novavax's Prototype Vaccine Shows Broad Immune Responses Incl. Against Omicron And Other Variants

Micron Technology Q3 Profit Increases, beats estimates

Antengene, BeiGene To Evaluate Selinexor Combination In T And NK-Cell Lymphoma

FDA Proposes Rule To Advance Consumer Access To OTC Drugs

Kezar Life Sciences Stock Surges 105% On Positive Data Drug Trial Results

Alaunos Extends Cooperative Research And Development Agreement With NCI

FDA Places Clinical Hold On Astellas' Phase 1/2 Trial Of AT845 In Late-Onset Pompe Disease

US To Get 21 Mln Bottles Of Bellamy's Organic Infant Formula From Australia

Walmart To Buy Memomi For Undisclosed Sum

Stanley Black & Decker To Divest Oil & Gas Business To Pipeline Technique

Jadestone Energy Appoints Bert-Jaap Dijkstra As New CFO

McDonald's Appoints Ian Borden To Succeed Kevin Ozan As CFO

US Supreme Court Turns Away Alaska Airlines Plea In Labor Law Case

Shoe Zone Sees FY22 Adj. Pretax Profit Not Less Than £8.5 Mln, Margin Growth; Stock Up

Keller Group Sees Full-year Performance Inline, Bags Order From S.Arabia 's NEOM Giga Project

TUI Repays Silent Participation II; Reduces KfW Credit Lines

Virgin Money UK To Repurchase 75 Mln Pounds Of Shares

Occidental Petroleum Up As Warren Buffett Adds Stock

Stagecoach FY Adj. Pretax Profit Rises

Booz Allen Disagrees With U.S. DoJ's Characterization Of Proposed EverWatch Deal

Ascletis' ASC22 Shows Potential Of Functional Cure Of Chronic Hepatitis B In Phase IIb Trial

Barnes & Noble Education, Inc. Q4 Loss Decreases